Structure–Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy-Reference-Cited by-同舟云学术

Structure–Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy

Published:2018-07-18 Issue:24 Volume:61 Page:10957-10975
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Acúrcio Rita C.¹,Scomparin Anna²,Conniot João¹,Salvador Jorge A. R.³,Satchi-Fainaro Ronit²,Florindo Helena F.¹^ORCID,Guedes Rita C.¹^ORCID

Affiliation:

1. Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal

2. Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, 6997801 Tel Aviv, Israel

3. Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, and Centre for Neuroscience and Cell Biology, University of Coimbra, 3000-548 Coimbra, Portugal

Funder

European Regional Development Fund

Funda??o para a Ci?ncia e a Tecnologia

Ministry of Health, State of Israel

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00541

Reference119 articles.

1. Inflammation and cancer: back to Virchow?

2. CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA

3. Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge

4. Inhibitory B7-family molecules in the tumour microenvironment

5. Molecular mechanisms of T cell co-stimulation and co-inhibition

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and evaluation of antitumor activity of 2-arylmethoxy-4-(2-fluoromethyl-biphenyl-3-ylmethoxy) benzylamine derivatives as PD-1/PD-l1 inhibitors;European Journal of Medicinal Chemistry;2024-10

2. Design, Synthesis, and Evaluation of 8-(o-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 Antagonists;ACS Medicinal Chemistry Letters;2024-03-15

3. Optoelectronics properties;Quantum Chemistry Methods for Oncological Drugs;2024

4. Advances in Immunotherapy for Hepatocellular Carcinoma (HCC);Current Oncology;2023-11-07

5. Recombinant human TIM-3 ectodomain expressed in bacteria and recovered from inclusion bodies as a stable and active molecule;Frontiers in Bioengineering and Biotechnology;2023-07-31